It’s a stark new reality. And investors need to listen up or lose out. Truth be told, it is no longer only the size and grade of each new mineral discovery that determines whether it can become a mine. Now, all exploration/development projects also need to ...
Marc Davis
|
January 24, 2022
|
The stock exchange is not a one-way street, and for this reason, there are also fluctuations in price formation. There is no such thing as a fair valuation that statically determines the value of a share. Every investor has different motives in investment decisions and about t...
Mario Hose
|
October 2, 2020
|
There are hardly any sectors not affected by Covid-19, including the US solar industry. The US solar industry is affected by compounding issues, delays in supply chains, strengthening the tax equity market, financial concerns of homeowners, shelter-in-place orders, and challen...
Ved Prakash
|
May 22, 2020
|
As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...
Richard (Rick) Mills
|
April 24, 2020
|
Maurice Jackson: Today we will introduce an early-stage exploration company focused on identifying district-scale high-grade copper and silver systems in Peru. Joining us for our conversation is Michael Hudson, the CEO of Hannan Metals Ltd. (HAN:TSX.V; HANNF:OTCPK) . ...
Streetwise Reports
|
April 14, 2020
|
Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week. Enzo Biochem Inc. (ENZ:NYSE) today announced that "its wholly owned subsidiary, Enzo Clinical Labs Inc., will begin accep...
Streetwise Reports
|
March 9, 2020
|
Maurice Jackson of Proven and Probable speaks with Andy Schectman, president of Miles Franklin Precious Metals Investments, about the rationale for buying precious metals and the best values at this time. Maurice Jackson: Joining us for a conversation is And...
Streetwise Reports
|
February 6, 2020
|
Genprex's shares spiked 380% higher in morning trading as the company reported that the FDA granted Fast Track Designation for its Oncoprex immunogene therapy in combination with EGFR inhibitor osimertinib. This morning, Genprex Inc. (GNPX:NASDAQ) , which "utilizes a...
Streetwise Reports
|
January 22, 2020
|
The quarterly highlights are provided in a Raymond James report. In a Nov. 7 research note, Raymond James analyst John Freeman wrote that Kimbell Royalty Partners, LP (KRP:NYSE) "reported record production in Q3/19, making way for about an 8% sequential distribution...
Streetwise Reports
|
November 26, 2019
|
News does drive certain market events and we understand how certain traders rely on news or interest rates to bias their positions and trades. As technical analysis purists, so to say, we believe the price operates within pure constructs of price rotation theory, trend theory,...
Chris Vermeulen
|
November 13, 2019
|